Claims
- 1. A process for preparing modified polyacrylonitrile, comprising treatment polyacrylonitrile with an effective amount of a nitrile hydratasis enzyme at an enzymatically active temperature and pH, wherein surface --CN groups of said polyacrylonitrile are hydrolyzed to --CO--NH.sub.2 groups, wherein said treating is carried out with stirring in the presence of 2,000-12,000 U/ml of said enzyme on 0.2-2 grams of said polyacrylonitrile, in a medium containing 100 mM phosphate buffer at pH 7, at a temperature of 10.degree.-30.degree. C. for 12-24 hours.
- 2. The process of claim 1, wherein said polyacrylonitrile is treated with whole or partially purified cellular lysates of Brevibacterium bacteria containing said enzyme.
- 3. The process of claim 2, wherein said Brevibacterium bacteria is Brevibacterium imperiale.
- 4. The process of claim 2, wherein said Brevibacterium bacteria is Brevibacterium imperiale CBS 49874.
- 5. The process of claim 1, wherein said medium further comprises 1-3% v/v of dimethyl formaldehyde.
- 6. A process for preparing modified polyacrylonitrile, comprising treating polyacrylonitrile with an effective amount of a nitrile hydratasis enzyme at an enzymatically active temperature and pH, wherein surface --CN groups of said polyacrylonitrile are hydrolyzed to --CO--NH.sub.2 groups, wherein said polyacrylonitrile is in the form of a non-yarn polymer having an average polymer diameter between 10-200 microns.
- 7. A process for preparing modified polyacrylonitrile, comprising treating polyacrylonitrile with an effective amount of a nitrile hydratasis enzyme at an enzymatically active temperature and pH, wherein surface --CN groups of said polyacrylonitrile are hydrolyzed to --CO--NH.sub.2 groups, wherein said polyacrylonitrile is in the form of a polymer yarn, fiber or weave, having an average fiber diameter between 10-30 microns.
- 8. The process of claim 1, wherein said polyacrylonitrile is an acrylonitrile homopolymer or copolymer of acrylonitrile and a vinyl ester or acrylate.
- 9. The process of claim 6, wherein said polyacrylonitrile is treated with whole or partially purified cellular lysates of Brevibacterium bacteria containing said enzyme.
- 10. The process of claim 9, wherein said Brevibacterium bacteria is Brevibacterium imperiale.
- 11. The process of claim 9, wherein said Brevibacterium bacteria is Brevibacterium imperiale CBS 49874.
- 12. The process of claim 6, wherein said medium further comprises 1-3% v/v of dimethyl formaldehyde.
- 13. The process of claim 6, wherein said polyacrylonitrile is an acrylonitrile homopolymer or copolymer of acrylonitrile and a vinyl ester or acrylate.
- 14. The process of claim 7, wherein said polyacrylonitrile is treated with whole or partially purified cellular lysates of Brevibacterium bacteria containing said enzyme.
- 15. The process of claim 14, wherein said Brevibacterium bacteria is Brevibacterium imperiale.
- 16. The process of claim 14, wherein said Brevibacterium bacteria is Brevibacterium imperiale CBS 49874.
- 17. The process of claim 14, wherein said medium further comprises 1-3% v/v of dimethyl formaldehyde.
- 18. The process of claim 14, wherein said polyacrylonitrile is an acrylonitrile homopolymer or copolymer of acrylonitrile and a vinyl ester or acrylate.
Parent Case Info
This is a division of application Ser. No. 08/363,875 filed on Dec. 27, 1994, pending.
US Referenced Citations (4)
Number |
Name |
Date |
Kind |
4390631 |
Watanabe et al. |
Jun 1983 |
|
4851342 |
Watanabe et al. |
Jul 1989 |
|
4908313 |
Satoh et al. |
Mar 1990 |
|
5302528 |
Battistel et al. |
Apr 1994 |
|
Divisions (1)
|
Number |
Date |
Country |
Parent |
363875 |
Dec 1994 |
|